Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]

Use of genetic variance to identify potential therapeutic targets

Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA

Use of genetic variance to identify potential therapeutic targets ( Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA )

Application of next generation sequencing

Dr Gary Palmer – Foundation Medicine, Cambridge, USA

Application of next generation sequencing ( Dr Gary Palmer – Foundation Medicine, Cambridge, USA )

Next generation sequencing and WIN therapeutics

Dr Michael Pellini – Foundation Medicine, Cambridge, USA

Next generation sequencing and WIN therapeutics ( Dr Michael Pellini – Foundation Medicine, Cambridge, USA )

Identifying targets with systems medicine

Dr Leroy Hood – Institute for Systems Biology, USA

Identifying targets with systems medicine ( Dr Leroy Hood – Institute for Systems Biology, USA )

Shortening the timeline for clinical drug developments

Dr James Doroshow – National Cancer Institute, Bethesda, USA

Shortening the timeline for clinical drug developments ( Dr James Doroshow – National Cancer Institute, Bethesda, USA )

Building international collaborations and the WINTHER trial

Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA

Building international collaborations and the WINTHER trial ( Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA )

GFI is crucial for AML1-ETO induced acute myeloid leukemia

Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland

GFI is crucial for AML1-ETO induced acute myeloid leukemia ( Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland )

Signaling and targeting cellular pathways in leukaemia metabolism

Dr Jing Chen – Emory University School of Medicine, Atlanta, USA

Signaling and targeting cellular pathways in leukaemia metabolism ( Dr Jing Chen – Emory University School of Medicine, Atlanta, USA )

Whole genome sequence analysis for acute lymphoblastic leukaemia

Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA

Whole genome sequence analysis for acute lymphoblastic leukaemia ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )

Next generation sequencing and the monoclonal structure of multiple myeloma

Dr Niccolo Bolli – University of Cambridge, UK

Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland

Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )

New drugs for relapsed and refractory Hodgkin's lymphoma

Prof Anas Younes - MD Anderson Cancer Center, Houston, USA

$New drugs for relapsed and refractory Hodgkin's lymphoma ( Prof Anas Younes - MD Anderson Cancer Center, Houston, USA )$

More from ecancer